Showing results (91-100 of 167) with videos related to

Sort By:
Pageof 17
Cancer Investigation|February 7, 2001
Prognostic role of K-ras in patients with progressive colon cancer who received treatment with Marimastat (BB2516)J Nemunaitis, J Cox, S Hays, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 9, 2009
Phase II trial of talabostat and docetaxel in advanced non-small cell lung cancerR M Eager, C C Cunningham, N Senzer, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 26, 2013
A phase I trial of oral ridaforolimus (AP23573; MK-8669) in combination with bevacizumab for patients with advanced cancersJ Nemunaitis, H S Hochster, S Lustgarten, et al.
Cancer|September 26, 2001
A Phase I trial of H-ras antisense oligonucleotide ISIS 2503 administered as a continuous intravenous infusion in patients with advanced carcinomaC C Cunningham, J T Holmlund, R S Geary, et al.
Experimental Hematology|April 1, 1993
Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitroR Maze, M Horie, P Hendrie, et al.
Cancer Gene Therapy|March 17, 2009
Phase II trial of Belagenpumatucel-L, a TGF-beta2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patientsJ Nemunaitis, M Nemunaitis, N Senzer, et al.
Cancer Gene Therapy|October 25, 2008
MicroRNA profile analysis of human prostate cancersA W Tong, P Fulgham, C Jay, et al.
Gene Therapy|June 23, 2001
Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activityJ Nemunaitis, C Cunningham, A Buchanan, et al.
Blood|May 15, 1992
Phase II trial of recombinant human granulocyte-macrophage colony-stimulating factor in patients undergoing allogeneic bone marrow transplantation from unrelated donorsJ Nemunaitis, C Anasetti, R Storb, et al.
American Journal of Clinical Oncology|April 16, 1998
Prognostic value of K-ras mutations, ras oncoprotein, and c-erb B-2 oncoprotein expression in adenocarcinoma of the lungJ Nemunaitis, S Klemow, A Tong, et al.
Pageof 17